COMMUNIQUÉS West-GlobeNewswire

ObsEva SA Announces the Completion of Patient Recruitment in the IMPLANT2 Phase 3 Clinical Trial in Assisted Reproductive Technology Ahead of Schedule

06/09/2017 - 13:00

Geneva, Switzerland and Boston, MA - 06 September, 2017 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]

Faron Pharmaceuticals Oy: Interim Results for the six months ended 30 June 2017

06/09/2017 - 13:00

Faron Pharmaceuticals Ltd ("Faron" or the "Company") Interim Results for the six months ended 30 June 2017 INTEREST Phase III Traumakine ® trial patient recruitment to complete in Q4 2017 and FDA advice received [...]

Helsinn Group: Announces Upcoming Presentation of Phase III data of NEPA (fosnetupitant/ palonosetron) IV at ESMO 2017

06/09/2017 - 09:30

Helsinn Group Announces Upcoming Presentation of Phase III data of NEPA (fosnetupitant/ palonosetron) IV at ESMO 2017 Preliminary findings demonstrate intravenous NEPA to be safe and well-tolerated, with a similar [...]

BioNTech AG Enters into Licensing Agreement with CELLSCRIPT, LLC as it Advances Development of Messenger RNA Encoding Bispecific Antibodies and other Therapeutic Proteins

06/09/2017 - 08:00

MAINZ, Germany, Sept. 06, 2017 (GLOBE NEWSWIRE) -- BioNTech AG, a fully integrated biotechnology company pioneering individualized cancer immunotherapy, today announced that it has entered into a broad and comprehensive [...]

MDxHealth Prepares for Growth with Executive Team Expansion

06/09/2017 - 07:00

Michael K. Brawer, MD Appointed as Chief Medical Officer PRESS RELEASE / REGULATED INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, September 6, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced the [...]

MDxHealth consolide son équipe de direction pour accompagner la croissance

06/09/2017 - 07:00

Michael K. Brawer, MD est nommé Chief Medical Officer COMMUNIQUÉ DE PRESSE / INFORMATIONS RÉGLEMENTÉES IRVINE, CA, et HERSTAL, BELGIQUE - 07:00 CEST, 6 septembre, 2017 - MDxHealth SA (Euronext : MDXH.BR) a annoncé la [...]

Novavax to Participate in the Citi 12th Annual Biotech Conference

05/09/2017 - 22:05

GAITHERSBURG, Md., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced the Company will participate in Citi's 12th Annual Biotech Conference. Conference details are as follows: Date: Thursday [...]

Medtronic EVP & CVG President Mike Coyle to Speak at Wells Fargo Healthcare Conference

05/09/2017 - 21:30

DUBLIN - September 5, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the 2017 Wells Fargo Healthcare Conference on Thursday, September 7, 2017, in [...]

PCI Biotech: Exercise of employee share options, mandatory notification of trade and resolution to increase the share capital

05/09/2017 - 20:54

Oslo (Norway), 5 September 2017 - Exercise of employee share options, mandatory notification of trade and resolution to increase the share capital in PCI Biotech Holding ASA (the "Company"). 1. Options exercised and [...]

Diaxonhit : acquisition définitive la société GENBIO aux Etats-Unis

05/09/2017 - 18:27

DIAXONHIT acquiert la société GENBIO aux Etats-Unis Réalisation de l'acquisition stratégique d'une entreprise commerciale pour accélérer le développement du groupe aux Etats-Unis et à l'international GENBIO, une société [...]

VALNEVA : Déclaration d'actions et de droits de vote - août 2017

05/09/2017 - 18:00

VALNEVA Déclaration d'actions et de droits de vote - AOUT 2017 Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon - Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché [...]

DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social

05/09/2017 - 17:54

Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]

DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company

05/09/2017 - 17:54

Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]

Medtronic Launches Long Term Clinical Study Program of INFUSE Bone Graft in Two Common Spine Procedures: PLF and TLIF

05/09/2017 - 15:00

First Patient Enrolled in Initial Posterolateral Fusion Study DUBLIN - September 5, 2017 - Medtronic plc (NYSE: MDT) today announced the launch of a long term clinical study program to collect prospective data on INFUSE [...]

Helsinn Therapeutics (U.S.) Inc., Signs Co-Promotion Agreement for Cancer Therapeutic Zykadia® in the US

05/09/2017 - 14:15

Helsinn Therapeutics (U.S.) Inc., Signs Co-Promotion Agreement for Cancer Therapeutic Zykadia ® in the US Zykadia ® (ceritinib) is an approved treatment for patients with metastatic non-small cell lung cancer (NSCLC) [...]

Minerva Neurosciences Announces Enrollment of First Patient in Phase 2b Trial of Seltorexant (MIN-202) as Adjunctive Therapy in Patients With Major Depressive Disorder

05/09/2017 - 14:00

WALTHAM, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]

Auris Medical to Host Scientific Symposium at the AAO-HNSF Annual Meeting

05/09/2017 - 14:00

ZUG, Switzerland, Sept. 5, 2017 (GLOBE NEWSWIRE) -- Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, [...]

Apricus Biosciences to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

05/09/2017 - 13:00

SAN DIEGO, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Richard W. Pascoe, [...]

Summit Therapeutics plc : Positive Top-line Phase 2 Results

05/09/2017 - 13:00

Summit Therapeutics plc ('Summit' or the 'Company') SUMMIT ANNOUNCES POSITIVE TOP-LINE DATA FROM AN EXPLORATORY PHASE 2 CLINICAL TRIAL SUPPORTING RIDINILAZOLE AS A HIGHLY SELECTIVE ANTIBIOTIC FOR THE TREATMENT OF CDI [...]